More Articles

FDA receives application for first generic of HIV drug dolutegravir Generics/News | Posted 05/06/2015

India-based Aurobindo Pharma (Aurobindo) has submitted an abbreviated new drug application (ANDA) for HIV treatment dolutegravir for tentative approval, to the US Food and Drug Administration (FDA).

Generic opioid tops Medicare’s prescription chart Reports | Posted 05/06/2015

An analysis of Medicare’s prescription drug programme in the US has found that generics of the opioid painkiller Vicodin (hydrocodone/acetaminophen) was the most widely prescribed medicine to Medic...

Finnish drug regulator recommends interchangeability of biosimilars Policies & Legislation | Posted 29/05/2015

The Finnish Medicines Agency, Fimea, announced on 22 May 2015 that it was recommending the interchangeability of biosimilars for their reference biologicals.

Clinical trials for infliximab biosimilars Biosimilars/Research | Posted 29/05/2015

A systematic review into clinical trials for infliximab biosimilars was carried out as part of an investigation into biosimilars for the treatment of psoriasis by researchers from the Charité – Uni...

Physicians’ perceptions of HIV generics in France Generics/Research | Posted 29/05/2015

A study of French physicians in HIV clinics found that, while the majority of these physicians were willing to prescribe antiretroviral generics, a quarter of physicians were openly opposed to anti...

Incomplete processing in recombinant streptokinase Biosimilars/Research | Posted 29/05/2015

A study investigating the impact of incomplete processing on streptokinase activity has found that ‘similar biologics’ or different batches of the biological may have different potencies, depe...

Efforts to bring drug prices down in Ireland Reports | Posted 29/05/2015

Ireland’s Health Services Executive (HSE), which provides public health and social care services to everyone living in Ireland, reports that the average price of a pack of medicine provided to pati...

Latin American deal for infliximab biosimilar Biosimilars/News | Posted 29/05/2015

US-based Epirus Biopharmaceuticals (Epirus) announced on 14 May 2015 that it had made a deal with biosimilars specialist mAbxience, a subsidiary of Spanish healthcare firm the Chemo Group, for Lati...